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“Images in …” articles are 1 or 2 striking and clinically important images with a brief 
description and an educational message. Published “Images in …” articles are 
available free online
Please DO NOT use this template to submit images (figures) for full case 
reports – you will be prompted to upload images during the submission 
process for both full cases and “Images in …” 
TITLE OF CASE 
Leptomeningeal dissemination of Spinal Pilocytic Astrocytoma: A rare entity. 
DESCRIPTION Up to 250 words summarising the importance of the image(s) 
A currently 12 year old boy presented at the age of 8-months with sleepiness, irritability and 
a tense fontanelle with upgaze palsy on a background of a 2 month history of vomiting, 
difficulty feeding and weight loss.  Acute communicating hydrocephalus was diagnosed using 
ultrasonography and CT and treated with VP shunt insertion. Further investigation with MR 
imaging (2006) found a thoracic intramedullary mass with further intracranial and spinal 
leptomeningeal dissemination (Figures 1 and 2).  A biopsy of the thoracic intramedullary 
mass showed pilocytic astrocytoma (PA) (Figure 3).  
He received intensive 85 weeks of chemotherapy (2006-2008) with low grade glioma protocol (SIOP-LGG 
2004), including Vincristine (1.125mg/m2 to 1.5mg/m2), carboplatin (412mg/m2-550mg/m2) and 
etoposide (100mg/m2). He responded well with almost complete resolution of metastatic 
disease (figure 4). There was no progression for several years till December 2016, when he 
developed a suprasellar/prepontine cystic area/loculated fluid with small eccentric enhancing 
nodule (figure 5); On further follow up, the cyst has become more well defined in 2017 and 
2018 scans with slight prominence of nodule (figure 6). The nodular enhancement in the 
spinal intramedullary lesion has also become slightly more prominent since june 2017 
(Figure 6) with otherwise overall stable appearances, there has been however no change in 
neurological status. He is currently neurologically and developmentally well. His main 
problem has been progressive thoracic and lumbar scoliosis secondary to thoracic tumour; 
stabilised with bracing since 2011. Due to concerns of destabilisation, and following pubertal 
maturation, the patient underwent elective posterior spinal fusion T2-4 with instrumentation 
and bone graft. He underwent posterior spinal fusion in 2017. He remains well, 10 years post 
treatment, with ongoing disease surveillance. 
PA is the most common paediatric brain tumour accounting for ~20% of paediatric brain 
tumours.[1] PA usually arise in the posterior fossa, hypothalamic region or optic chiasm (often 
associated with Neurofibromatosis-1), occasionally in the cerebral hemispheres, and extremely 
rarely, in the spinal cord. Almost all are associated with single abnormalities of the mitogen-
activating-protein-kinase (MAPK) pathway.  While PA are Grade 1 tumours, they occasionally 
can exhibit more aggressive behaviour such as malignant transformation, recurrence or 
leptomeningeal dissemination (LD).[2,3] LD in PA is a rare occurrence, with less than 100 
reported cases in the literature and even more rarely occurring with a spinal primary with 
only 4 reported cases.[2,4]  Around half of cases of LD present at diagnosis.[1] It is not 
known, why LD, particularly with a spinal primary is such a rare occurrence. There is a 
possibility that it represents a distinct entity or has a specific phenotype, however, this will 
need further analysis. While LD can present with hydrocephalus, many are identified 
incidentally.[4] Since the number of known LD are very low, there are no known factors 
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described to suggest its occurrence, however, any change in neurological status and any 
clinical suspicion of raised intracranial pressure should prompt further imaging to exclude its 
occurrence. PA is primarily treated with surgery, and occasionally, with radiotherapy and/or 
chemotherapy, while targeted therapies hold promise. Prognosis is excellent; with 10-year 
survival >90%, falling to <50% for patients with LD.[4] As this case demonstrates however that 
despite leptomeningeal dissemination, these patients can still have a relatively long and 
indolent course. This case report is intended to serve as a reminder of this rare and often 
chronic condition. 
 
LEARNING POINTS/TAKE HOME MESSAGE 2 to 3  bullet points – this is a required 
field 
 
- Pilocytic astrocytomas, while Grade 1 tumours, can rarely metastasize with 
leptomeningeal dissemination. 
- Leptomeningeal dissemination can present incidentally, either at diagnosis 
or later, but can be symptomatic and may present as hydrocephalus. 
- Despite early leptomeningeal dissemination, the patients can have a long 
and indolent course with a relatively stable disease over long periods. 
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FIGURE/VIDEO CAPTIONS figures should NOT be embedded in this document 
 
Figure 1: Initial MRI Whole spine (2006). (a) T2 sagittal, (b) T1 sagittal and (c) 
Post contrast T1 sagittal. Black arrows in (a) and (b) show upper thoracic 
intramedullary mass. This white arrow in (c) shows no significant enhancement. 
Thick white arrows (c) shows leptomeningeal enhancement. 
 
Figure 2: Initial MRI Brain (2006). (a) T1 sagittal without contrast. (b) T1 sagittal 
with contrast. (c-f). T1 axial post contrast images. White arrows in b-f show 
several areas of leptomeningeal dissemination. 
 
Figure 3: Histopathology shows solid and less solid areas with Rosenthal fibres and 
elongated cell nuclei with long fibrillary processes consistent with Pilocytic 
astrocytoma. 
 
Figure 4. Post chemotherapy scan (2008). (a) T2 sagittal of spine. (b) T1 post 
contrast sagittal of spine. (c,d), T1 post contrast axials brain. (a,b) show stable 
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appearances of intramedullary mass and resolution of leptomeningeal 
dissemination. (c,d) show resolution of intracranial leptomeningeal dissemination. 
 
Figure 5. Follow up scan (2016). (a,b) T2 and T1 sagittal post contrast images of 
spine. (c,d,e) T1 post contrast axial, sagittal and coronal images of brain. (a,b) 
show stable appearance of intramedullary mass (white arrows). Thick white arrow 
in (d) shows a CSF/fluid loculation in suprasellar region with draping of optic tract 
over it (broken arrow). Thin white arrows in (c,e) show small eccentric enhancing 
nodule on left side. 
 
Figure 6. Follow up scan (2017). (a,b) T2 and T1 sagittal post contrast images of 
spine. (c,d) T1 post contrast axial and sagittal images of brain. (a,b) show 
increasing scoliosis. White arrow in (b) show nodular enhancing lesion slightly 
more prominent than previous images. White arrow in (c) shows nodular 
enhancement in suprasellar resion. White arrow in (d) shows more well defined 
fluid/loculated component. 
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